Scholarlink

<p>Diagnosing neonatal pyruvate kinase (PK) deficiency is challenging, especially when early transfusions render conventional testing inconclusive. Genetic testing, however, is not influenced by transfusions and can provide, in most cases, a definitive diagnosis. We report two unrelated infants with symptomatic PK deficiency, both compound heterozygous for <i>PKLR</i> mutations, including two undescribed missense variants (c.865C&gt;T; p.(Arg289Trp) and c.1016A&gt;G; p.(Asp339Gly)). These cases underscore the critical role of molecular testing —particularly hereditary hemolytic anemia next-generation sequencing (NGS) panels—in confirming the diagnosis when enzymatic assays are unfeasible, further shortening time to diagnosis in congenital hemolytic anemias.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Expanding the PKLR mutation spectrum: discovery of two novel variants in two pediatric cases of pyruvate kinase deficiency

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Oliver Sakalian,
  • Yoann Huguenin,
  • Serge Pissard,
  • Vanessa Augis,
  • Laurent Weinmann,
  • Valérie Fuster,
  • Marie Lagarde,
  • Elise Badour,
  • Nathalie Aladjidi,
  • Julian Boutin,
  • Stéphanie Dulucq

摘要

Diagnosing neonatal pyruvate kinase (PK) deficiency is challenging, especially when early transfusions render conventional testing inconclusive. Genetic testing, however, is not influenced by transfusions and can provide, in most cases, a definitive diagnosis. We report two unrelated infants with symptomatic PK deficiency, both compound heterozygous for PKLR mutations, including two undescribed missense variants (c.865C>T; p.(Arg289Trp) and c.1016A>G; p.(Asp339Gly)). These cases underscore the critical role of molecular testing —particularly hereditary hemolytic anemia next-generation sequencing (NGS) panels—in confirming the diagnosis when enzymatic assays are unfeasible, further shortening time to diagnosis in congenital hemolytic anemias.